CSI Market
Sign In | Register

Marizyme Inc (MARZ) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access MARZ Annual Cash Flow →
Observing cash flow movements over recent quarters helps explain how Marizyme Inc adapts cash usage as operating conditions change.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2024)
9 Months 		(Jun 30 2024) (Mar 31 2024) (Dec 31 2023) (Sep 30 2023)
Operating Activities
Income-14.79
Depreciation & amortization0.34
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.12
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt3.89
Professional Fees-
Stock Issued During Period Value Issued For Services-
Stock Based Compensation-
Issuance Of Common Stock For Services-
Stockbased Compensation Restricted Common Stock-
Interest And Accretion Expenses6.23
Issuance Of Warrants For Services-
Loss On Issuance Of Debt-
Shares Issued As Part Of Confidential Settlement Agreement-
Shares Issued For Services-
Depreciation Depletion And Amortization-
Operating Lease Right Of Use Asset Amortization Expense0.30
Shares Issued For Legal Settlement-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts and Other Receivables0.06
Accounts Payable0.07
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense-0.03
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities1.29
Discontinued operations0.00
Net Cash flow from Operating Activities-2.52
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Writedown Goodwill And Intangibles-
Proceeds From Sale Of Subsidiaries-
Write Down Goodwil L Andi Ntangibles-
Goodwill And Intangible Asset Impairment-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net2.36
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-0.42
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.50
Debt Instrument Decrease Forgiveness-
Proceeds From Promissory Notes Due To Related Parties-
Proceeds From Notes Payable Related Parties-
Proceeds From Financing Net Of Issuance Cost-
Proceeds From Financing Net Of Issuance Costs-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities2.44
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-2.52
Total Cash Flow-0.08
4 historic quarters locked

Sign in to unlock the full Marizyme Inc cash flow history.

Sign In Create Free Account

About Marizyme Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20240930)
  • Filed with the SEC: March 5, 2025
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001493152-25-009226

Figures are derived from filed reports and may be restated. Historical data is subject to revision.